![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2017
Kieslich, Anna; Ruf, Peter; Lindhofer, Horst; Buhmann, Raynold; Eggert, Angelika und Hundsdörfer, Patrick
(2017):
Immunotherapy with the trifunctional anti-CD20xanti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
In: Leukemia & Lymphoma, Bd. 58, Nr. 8: S. 1989-1992
2011
Ströhlein, Michael A.; Lordick, Florian; Rüttinger, Dominik; Grützner, Klaus-Uwe; Schemanski, Oliver C.; Jäger, Michael; Lindhofer, Horst; Hennig, Michael; Jauch, Karl-Walter; Peschel, Christian und Heiss, Markus M.
(2011):
Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial.
In: Onkologie, Nr. 3: S. 101-108
[PDF, 349kB]
2009
Stroehlein, Michael A.; Siegel, Robert; Jaeger, Michael; Lindhofer, Horst; Jauch, Karl-Walter und Heiss, Markus M.
(2009):
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis.
In: Journal of Experimental & Clinical Cancer Research
28:18
[PDF, 322kB]